Figure 4.
In the BENEDICT study, the extent of systolic blood pressure (SBP) reduction had a specific and independent effect against the development of microalbuminuria. Angiotensin converting enzyme inhibitor (ACEi) therapy had a further protective effect, in particular when the SBP was less effectively controlled (inset).